Joint Ai, a Pittsburgh, PA–based AI-powered triage platform for orthopaedic teams treating arthritis patients, has secured a $315,000 investment.
Investors
The investment was from Richard King Mellon Foundation through its Social-Impact Investment Program.
Founded in 1947, the Richard King Mellon Foundation is the largest foundation in Southwestern Pennsylvania and one of the 50 largest in the world. As of year-end 2024, the Foundation’s net assets totaled $3.1 billion, and in 2024 its Trustees disbursed more than $155 million in grants and program-related investments. The Foundation focuses its funding on six primary program areas, outlined in its 2021–2030 Strategic Plan.
Joint Ai Use of Funds
The company will use the funds to enhance its technology, expand partnerships, and increase access to orthopaedic surgeons across the U.S..
About Joint Ai
Founded by Dr. Anthony DiGioia, Joint Ai is a healthtech company developing an AI-powered clinical decision aid for orthopaedic teams. Its platform combines X-ray imaging with patient-reported outcomes (PROs) to provide comprehensive assessments of knee and hip health, helping clinicians evaluate, diagnose, and recommend personalized treatment pathways for arthritis patients. Headquartered in Pittsburgh, Pennsylvania, Joint Ai’s mission is to reduce the time required for patient evaluations and triage while improving access to care.
Funding Details
Company: Joint Ai
Raised: $0.315M
Round: Seed / Social-Impact Investment
Funding Date: September 2025
Lead Investor: Richard King Mellon Foundation
Additional Investors:
Company Website: https://www.jointai.co/
Software Category: Healthtech / Clinical Decision Support AI
Source: https://www.businesswire.com/news/home/20250904010049/en/